PharmaDeals Review Business Commentaries
Dr Fintan Walton, PharmaVentures’ CEO, provides monthly comment on topical biotechnology and pharmaceutical industry issues. Includes access to Fintan’s commentaries broadcast on PharmaTelevision.
- Published on: 2006-04-01 The Impact of Clinical Risk Fintan Walton talks about the impact of clinical risk.
- Published on: 2006-03-01 Diagnose This Fintan Walton talks about the importance of using advanced diagnosis methods to combat disease.
- Published on: 2006-02-01 What's Special About Speciality? Fintan Walton discusses the buzz at the JP Morgan Annual Healthcare Conference in San Francisco in January 2006
- Published on: 2006-01-01 Is Your Company 'Corpomorphic'? Fintan Walton discusses how a biotech's ability to morph is essential to survival and success.
- Published on: 2005-12-01 Communication, Trust and the Deal Fintan Walton discusses the importance of communication and its impact on trust and effective deal making.
- Published on: 2005-11-01 Be Quick, be Brave, be Successful Whether you are a large corporation or a smaller biotech company, everybody needs to in-license or acquire innovation to build portfolios. So who are the successful ones?
- Published on: 2005-10-01 Where Does Innovation Prosper? Where are the optimal conditions for innovation to most successful?
- Published on: 2005-09-01 Antipodean Innovation Biotech innovation is booming in Australia and New Zealand.
- Published on: 2005-08-01 Biotechnology Means Hope Demand for lower priced drugs and the risk associated with their development means that the right financial environment is crucial to enable biotechnology to deliver on its promise. The industry now needs government support to allow it to take on the substantial risk of drug development.
- Published on: 2005-07-01 Don't Make Your Drug Deals Poison Pills It is relatively easy to formulate a corporate strategy for investor exit but much harder to implement it. IPOs or trade sales through M&A, for example, may require entirely different partnering strategies, which is why benchmarking has to be carefully thought through.
Bookmarks
Bookmark PharmaDeals through one of these social networks.
